Kirilys Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2022-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://kirilys.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of ASN004 in Patients With Advanced Solid Tumors
- First Posted Date
- 2020-06-01
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Kirilys Therapeutics Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT04410224
- Locations
- 🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸NEXT Oncology, San Antonio, Texas, United States
🇺🇸Next Oncology, Fairfax, Virginia, United States
News
No news found